Contents:

TOM* - EICOSANOID SYSTEM AND ENDOTHELIUM:THE ROLE IN INFLAMMATION AND ATHEROSCLEROSIS

....................................................

THE IMPORTANCE OF HOMOCYSTEINE IN PATIENTS UNDERGOING CORONARY BY-PASS SURGERY

....................................................

NUCLEOSIDES AND NUCLEOSIDE ANALOGUES IN THE HEART – TRANSPORT AND ROLES

....................................................

THE ROLE OF POTASSIUM CHANNEL MODULATORS IN THE MODERN CARDIOVASCULAR THERAPY

....................................................

THE INFLUENCE OF DIFFERENT CALCIUM CHANNEL ANTAGONISTS ON CORONARY CIRCULATION OF THE ISOLATED RAT HEART: INTERACTION WITH L-ARGININE: NO SYSTEM

....................................................

ARTERIAL HYPERTENSION IN DIABETES MELLITUS

....................................................

THE IMPORTANCE OF LEFT VENTRICULAR FUNCTION FOR EARLY AND DEFFINITIVELLY PROGNOSIS OF ACUTE MYOCARDIAL INFARCTION

....................................................

ENDOTHELIAL CELL (DIS)FUNCTION IN PREECLAMPSIA

....................................................
 

 

 

 



ARTERIAL HYPERTENSION IN DIABETES MELLITUS

Ljiljana M. Bajovic1
1Department of Endocrinology, CHC „Kragujevac, Medical Faculty, Kragujevac

Received: 23. 10. 2000. Accepted: 07. 11. 2000.

 

ABSTRACT


Arterial hypertension and diabetes mellitus are powerful and independent risk factors for development of blood vessels disease (coronary, cerebro-vascular and peripherial diseases), as well as kidney disease. Simultaneous motion of hypertenson and diabetes mellitus does not essentialy represent the risk factor calculation; moreover, it represents serious condition of exponentially increased risk.
HTA (hypertension) is two times more likely to occur in patients with Diaebetes mellitus (DM), and is often coupled with diabetes nephropathy. HTA incidence in DM type II is higher (67 %), than in DM type I and is often registered at the time when diagnosis for DM type II is established (patophysiological nature of developing manifestable DM type II begins about 12 years before it is diagnosed).
Rationale for HTA occurence in DM is: genetic predisposal, endothelial dysfunction, insulin resitance and number of other surrounding factors.
The goal of HTA therapy in DM is to prevent death, specific morbidity and invalidity, yet not to deteriorate glycoregulation, lyporegulation and chronic complications (peripheral, microangiopathy, nephropathy, etc.). HTA therapy in DM recommend the engagement of pharmacological and non-pharmacological measures that can be implemented in accordance with "step by step" principle, and it conceives very complex therapy.
Pharmacological characteristics of antihypertensives have to be taken into consideration, as well as other potential side effect diseases. The aimed value is less than 130/80 mm Hg (JNC). As the first step the therapy suggest the use of medicaments from „the front line antyhypertesives“ ACE inhibitors or cardioselected b-adrenergic blockers, calcium channel blockers, and in case the retntion of natrium and water appears, the diuretics are added (only small doses).
Uncured hypertension in Diabetes Mellitus highly increases the risk for develloping of chronic macro- and microangiopathic complications.

Keywords: arterial hypertension, diabetes, endothelial dysfunction

 

The largest site for medical and bioscience journals, associations and databases

Correspodence to:
Ljiljana Bajovic, MD, PhD
Department of endocrinology CHC "Kragujevac"
34000 Kragujevac
phone: 034/370-023/ext. 408 fax: 034/335-321